CBER

Marks

FDA's Peter Marks shares more on CAR-T secondary cancer probe

Among 22 cases tracked so far, CAR insertion was detected in the malignant clone in each of the three cases for which sequencing was performed.

Angus Liu Jan 25, 2024 10:42am

FDAs Peter Marks

FDA's Marks went against reviewers' call on Sarepta's Elevidys

Jun 26, 2023 11:35am

Dementia

FDA signs off on booster, says another could be on its way

Mar 29, 2022 3:04pm